SCHEMBL453318

SCHEMBL453318

C=C(C)C(=O)OCc1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
MAPT P10636 2/20 0.51
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
POLB P06746 1/20 0.49
RAB9A P51151 1/20 0.49
MMP9 P14780 2/20 0.48
MMP1 P03956 1/20 0.48
IDO1 P14902 2/20 0.47
AGXT P21549 2/20 0.47
MMP2 P08253 1/20 0.47
MMP12 P39900 1/20 0.47
FFAR1 O14842 1/20 0.46
LDHA P00338 1/20 0.46
ATM Q13315 1/20 0.46
FABP7 O15540 1/20 0.46
FABP5 Q01469 1/20 0.46
P2RX4 Q99571 1/20 0.46
F2RL1 P55085 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18432901 0.95 ALDH1A1 (0.49) ALDH1A1MAPTHTTSMN1; SMN2NPC1
SCHEMBL8640696 0.94 ALDH1A1 (0.48) ALDH1A1MAPTHTTSMN1; SMN2NPC1
SCHEMBL8644721 0.91 HTT (0.53) ALDH1A1MAPTHTTSMN1; SMN2NPC1
SCHEMBL254038 0.89 ALDH1A1 (0.50) ALDH1A1HTTPOLB
SCHEMBL9111012 0.89 ALDH1A1 (0.44) ALDH1A1MAPTHTTSMN1; SMN2NPC1
SCHEMBL10904059 0.88 POLB (0.44) ALDH1A1MAPTHTTSMN1; SMN2POLB
SCHEMBL3758807 0.87 ALDH1A1 (0.60) ALDH1A1MAPTHTTSMN1; SMN2NPC1
SCHEMBL16256542 0.85 ALDH1A1 (0.44) ALDH1A1MAPTHTTSMN1; SMN2NPC1
SCHEMBL19194552 0.85 ELANE (0.47) ALDH1A1MAPTHTTSMN1; SMN2POLB
SCHEMBL24019226 0.84 ALDH1A1 (0.46) ALDH1A1MAPTHTTNPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250389633-A1 SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE SLINGSHOT BIOSCIENCES, INC. (US) 2025-12-25 US claimed
US-20250298042-A1 ENGINEERED PARTICLES AS RED BLOOD CELL MIMICS AND COMPOSITIONS CONTAINING SAME FOR HEMATOLOGY SLINGSHOT BIOSCIENCES, INC. (US) 2025-09-25 US claimed
EP-4608872-A2 SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION Slingshot Biosciences, Inc. (US) 2025-09-03 EP claimed
US-12379387-B2 Engineered particles as red blood cell mimics and compositions containing same for hematology SLINGSHOT BIOSCIENCES, INC. (US) 2025-08-05 US claimed
EP-3256850-B1 HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME SLINGSHOT BIOSCIENCES INC (US) 2025-07-09 EP claimed
US-12352679-B2 Synthetic human cell mimic particle for cytometric or coulter device SLINGSHOT BIOSCIENCES, INC. (US) 2025-07-08 US claimed
EP-4577823-A2 COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION Slingshot Biosciences, Inc. (US) 2025-07-02 EP claimed
US-20250189428-A1 COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION SLINGSHOT BIOSCIENCES, INC. (US) 2025-06-12 US claimed
US-12312595-B2 Hydrogel particles as feeder cells and as synthetic antigen presenting cells SLINGSHOT BIOSCIENCES, INC. (US) 2025-05-27 US claimed
US-20250164373-A1 SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE SLINGSHOT BIOSCIENCES, INC. (US) 2025-05-22 US claimed
US-6657030-B2 High refractive index and hydrophilic monomers, a crosslinker, an initiator and water BAUSCH & LOMB INCORPORATED 2003-12-02 US claimed
US-6657029-B2 High refractive index monomer, greater amount of a hydrophilic monomer, crosslinker, and initiator; give water content; intraocular lenses BAUSCH & LOMB INCORPORATED 2003-12-02 US claimed
US-6657032-B2 High refractive index and hydrophilic monomers, a crosslinker, an initiator and water BAUSCH & LOMB INCORPORATED 2003-12-02 US claimed
US-20020049290-A1 High refractive index hydrogel compositions for ophthalmic implants VANDERBILT DAVID P (US) 2002-04-25 US claimed
US-20020042483-A1 High refractive index hydrogel compositions for ophthalmic implants VANDERBILT DAVID P (US) 2002-04-11 US claimed
US-20020042484-A1 High refractive index hydrogel compositions for ophthalmic implants BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) 2002-04-11 US claimed
US-20020037984-A1 High refractive index hydrogel compositions for ophthalmic implants VANDERBILT DAVID P (US) 2002-03-28 US claimed
US-6329485-B1 FOR INTRAOCULAR LENSES BAUSCH & LOMB INCORPORATED 2001-12-11 US claimed
US-6136926-A CURING WITH ETHYLENICALLY UNSATURATED ORGANOSILANE COMPOUND; HEATING BELOW SOFTENING POINT BOREALIS GMBH (AT) 2000-10-24 US claimed
WO-2000034804-A1 HIGH REFRACTIVE INDEX HYDROGEL COMPOSITIONS FOR OPHTHALMIC IMPLANTS BAUSCH & LOMB SURGICAL, INC. (US) 2000-06-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250389633-A1 SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE CD4, ICOS, CD69 ALDH1A1 3752/4885MAPT 1949/4885HTT 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.